Vectura Group plc is a public company listed on the London Stock Exchange. It specialises in developing inhaled therapies, principally for the treatment of respiratory diseases, bringing together key aspects of inhaled development; technologies, clinical and regulatory operations, and manufacturing for clinical trials.
The Company has a broad pipeline of products in clinical development and a portfolio of revenue-generating, marketed products.
Vectura was founded in 1997 and has approximatley 210 employees based in Chippenham, Wiltshire with additional facilities in Cambridge, UK and a small office in Boston, US.
Vectura's shares trade on the London Stock Exchange under the symbol VEC.
Share price information
For details about Vectura’s financial information.
More